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In all normal individuals, the IgA in the serum and secretions can be divided into 
two subclasses, IgAa and IgA~, on the basis of antigenic differences. IgAa constitutes 
80-90% of the IgA in serum (1-3), whereas approximately equal amounts of IgA1 and 
IgA2 occur in the secretions (2). 
Our previous studies have shown that although the IgA B cell distribution  in the 
peripheral circulation  reflects serum ratios of IgAa to IgA2, that  is,  80% of the cells 
express surface IgA1 and 20% bear IgA2 (4), the differentiation potential of peripheral 
blood lymphocytes in response to polyclonal B  cell activators is quite different and 
more closely resembles the  distribution  of IgAx and  IgA2 in  secretions.  In cultures 
stimulated with pokeweed mitogen (PWM)  for 7 d, 50% of the plasma ceils that are 
positive for cytoplasmic IgA are positive for IgA1 and 50% are positive for IgA2 (4). 
This suggests that the cells in the circulation that differentiate into IgA plasma cells 
in response to PWM may be cells migrating to the mucosal surfaces. The observation 
that most of the IgA released into the supernatants of these cultures  is dimeric, like 
IgA in secretions, rather than monomeric, like serum IgA (5), supports this hypothesis. 
To further investigate regulation  of IgA subclasses in  PWM-stimulated  cultures, 
IgA1 and  IgA2 were measured  in  culture  supernatants  by a  radioimmunoassay we 
have recently devised using monoclonal anti-IgA subclass antibodies  (3). The results 
demonstrate that although there are equal numbers of IgA1 and IgA2 plasma cells in 
PWM-stimulated cultures, >90% of the IgA released into the culture supernatant  is 
IgA1. This discrepancy cannot  be accounted  for by failure of the assay to detect  in 
vitro synthesized IgA2, selective loss or destruction of IgA2, delayed release of IgA2, or 
failure of IgA2 plasma cells to produce J  chain. 
Materials and Methods 
PWM Cultures.  Peripheral blood lymphocytes from healthy adult laboratory personnel were 
separated from heparinized  venous blood by Ficoll-Hypaque centrifugation. The cells were 
suspended in RPMI  1640 (Gibco Laboratories, Grand  Island Biological  Co.,  Grand  Island, 
NY) with 20% fetal calf serum (FCS)  at 5-10 ×  106 cells/ml and incubated in plastic petri 
dishes  at  37 °  for 45  min  to  partially  deplete  monocytes.  Nonadherent  lymphocytes were 
resuspended in RPMI 1640 with 2 mM glutamine,  100 U/ml penicillin,  100 mg/ml strepto- 
mycin, 0.05 mM 2 mercaptoethanol, and 20% FCS at a concentration of 106 cells/ml. Aliquots 
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of 0.2  ml were  distributed into the  wells  of flat-bottomed microtiter plates  (Costar,  Data 
Packaging, Cambridge, MA). 5 >1 of PWM (Gibco Laboratories) were added to each well. The 
cells were cultured at 37°C in humidified air with 5% CO= for various periods. The cells were 
harvested gently by pasteur pipette, counted, and then spun down. Supernatants were then 
removed and the cell pellet was either resuspended and spun onto glass slides by cytocentrifu- 
gation for cytoplasmic staining or lysed by sonication for quantitation of intracellular IgA. 
Cells used for cytoplasmic staining were  fixed for 20 min in 95% ethanol, 5% glacial acetic 
acid, then washed three times in phosphate-buffered saline (PBS). The hybridoma supernatant, 
anti-IgA1 or anti-IgA2, was layered over the cells, and the slides were incubated for 20 min at 
room temperature followed  by two washes  in PBS.  The cells were then stained with fluoro- 
chrome-tagged goat anti-mouse immunoglobulin,  washed twice, then stained with heterologous 
anti-human IgA or anti-,] chain that had been labeled with a contrasting fluorochrome. The 
cells were washed  again and then  mounted under a  coverslip and examined with  a  Zeiss 
fluorescence  microscope equipped with epi-illumination  and appropriate barrier filters  (Carl 
Zeiss, Inc., New  York).  To determine the proportions of IgA plasma cells positive for  each 
subclass,  slides  were  first  scanned under filters  selective  for  fluorescein fluorescence.  Cells 
positively stained for fluorescein-tagged anti-IgA were then examined under filters selective for 
rhodamine to detect  positive staining for  IgA1 or IgA2. At least  I00 IgA-positive cells were 
counted on every slide. 
For quantitation of intracellular IgA subclasses,  the  cells  were  washed  three  times, then 
resuspended at 107 cells/ml in PBS containing 1% FCS, and disrupted by sonication at 0°C for 
1 min at 20,000 cycles/s (Sonifer Cell Disruptor, Health Systems Ultrasonics, Inc., Plainview, 
NY).  The sonicate was clarified by centrifugation for  5 min at  12,800 g.  Initial experiments 
were  conducted in which  known quantities of IgA were  added  to  cells  before  sonication. 
Subsequent radioimmunoassay indicated that the procedure did not damage either subclass of 
IgA. 
Antibodies.  The production and characterization of the monoclonal anti-IgA1 and anti-IgA2 
antibodies (1-155-1 and 14-3-26, respectively)  have been previously described (4). The heterol- 
ogous  anti-human IgA was  produced by immunizing a  goat with  a  highly purified IgA1K 
myeloma protein. Antibodies to the kappa light chain and contaminating immunoglobulins 
were removed by sequential absorption over a series of Sepharose 4B columns to which Cohn 
Fraction II,  IgGK, or  IgMK myeloma proteins had  been covalently bound. The anti-IgA 
antibody was eluted from a column to which a purified IgA2 protein had been fixed to insure 
that the anti-IgA had no subclass specificity. 
The fluorochrome-tagged goat anti-mouse antibodies were a gift from Dr. M. D. Cooper and 
Dr. H. Kubagawa, University of Alabama, Birmingham, AL. These reagents did not cross react 
with human immunoglobulins. The rhodamine-labeled anti-J chain was  a  gift  from  Dr. J. 
Mestecky,  University of Alabama. 
Radioimmunoassay.  The radioiodination of the heterologous goat anti-human IgA and ra- 
dioimmunoassay were done as previously described  (3). The wells of microtiter plates were 
coated with a  1:500  dilution of hybridoma anti IgA1 or anti IgA2 ascites.  After remaining 
protein binding sites were blocked with bovine serum albumin (Sigma Chemical Co., St. Louis, 
MO), the culture supernatants or cell lysates were added in duplicate to wells at dilutions of 
1:2, 1:8, 1:32, and 1:128. After overnight incubation, the wells were washed and 10 ng of 1251- 
labeled heterologous goat anti-IgA was added. After 4 h the wells were washed, then counted 
in a  Beckman Gamma 4000  (Beckman Instruments, Fullerton, CA). A serum standard with 
known concentrations of IgA1 and IgA2 was run in all assays to generate a standard curve. The 
concentrations of IgA~ and IgA2 in the supernatants or cell pellet lysates were determined from 
this standard curve. 
Results 
Peripheral blood lymphocytes from 27 normal adults were stimulated with PWM 
for  7  d.  The  cultures were  then  harvested  and  the  plasma  cells  were  stained  by 
immunofluorescent techniques for cytoplasmic IgA and the IgA subclasses IgA1 and 
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F1o.  1.  Immunofluorescent staining of plasma cells from PWM-stimulated peripheral blood 
lymphocytes. (Left) Cells stained with heterologous fluorescein-tagged  goat anti-human IgA; (right) 
the same field examined with filters selective for rhodamine fluorescence demonstrates doubly 
stained cells positive for IgA2. 
Cells stained for IgAz were always as intensely stained with the heterologous anti IgA 
as those stained  for IgAa (Fig.  1). Of the plasma cells stained for IgA, 50.0 +  2.44% 
were also stained for IgA1, whereas 50.9 +  2.59% stained for IgA2. 
To  investigate  the  relationship  between  IgA plasma cells  and  IgA released  into 
supernatants,  IgA1  and  IgA2  were  measured  in  the  supernatants  of cultures  with 
varying proportions of IgAx and IgA2 plasma cells. As noted in Table I and Fig. 2, in 
all cultures <10% of the secreted IgA was IgA2. 
Previous experiments demonstrated a  predominance of IgA~ plasma cells early in 
the PWM response, at days 3 and 4;  however, by day 7 of culture, the proportion of 
IgA2 plasma cells was equal to that of IgA1 (5). This suggested that the maturation of 
IgA2 plasma  cells  might  be  delayed  compared  with  that  of IgA1,  and  that  if the 
culture period were extended, higher concentrations of IgAz might be found in culture 
supernatants.  Therefore, culture supernatants were harvested from cells cultured  for 
5,  7,  9,  or  12 d.  To verify that  the radioimmunoassay used  to measure IgA2 would 
detect IgA2 synthesized in vitro, lysates of the cell pellets from these cultures were also 
assayed for IgA1 and IgA2. A representative experiment is shown in Table II. In each 
of four experiments,  the amounts of IgA1 and IgA2 in  the cell pellets were approxi- 
mately equal, as would have been predicted from the results of cytoplasmic staining. 
However, the  amount  of IgA2 in  the  culture  supernatant  was  always <10%  of the 
total IgA, and this proportion did not increase with time. In all experiments there was 1618  IN  VITRO  REGULATION  OF  IgA  SUBCLASS  SYNTHESIS 
TABLE  I 
Experiment 
Cytoplasmic staining  IgA in supernatants* 
% 
l  7  55  1,836  59 
2  3  29  846  74 
3  0.4  43  188  18 
* Expressed as ng/10  a ceils cultured. 
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FIG.  2.  Culture supernatants  from  PWM-stimulated  lymphocytes from  six different  individuals 
were assayed for IgA1 ([]) and IgA2 (m). 
Day 5 
Pellet 
Supernatant 
Day 7 
Pellet 
Supernatant 
Day 9 
Pellet 
Supernatant 
Day 12 
Pellet 
Supernatant 
TABLE  II 
IgA~*  IgA2* 
53  480 
469  8 
335  387 
2,680  3i 
603  1,240 
3,108  93 
603  387 
3,108  62 
PWM-stimulated cultures of peripheral blood lymphocytes were harvested after various 
periods. IgA1 and [gA~ were measured in the culture supernatant and in [ysates of the 
washed cell pellets. 
* Expressed as ng/106 cells cultured. 
more IgAz in the cell pellet than in the culture supernatants,  in some cases as much 
as  90  times  more  (mean  ratio of IgAz in  pellet  to  IgA2 in  supernatant,  30.2:1).  In 
contrast,  there  was  always  more IgAa  in  the  culture  supernatants  than  in  the  cell 
pellet,  sometimes as much as 30  times more  (mean ratio of IgA~  in  supernatant  to 
IgA1 in pellet 12.5:1). 
To  determine  if IgAz in  culture  supernatants  was  selectively lost,  purified  IgA2 
myeloma proteins were added at the beginning of the culture period. When 4,000 ng/ 
ml of an IgA~ (allotype Am2-) or an IgAzK (allotype Am2 +) were added at day 0, 
3,320 ng and 2,680 ng, respectively, were retrieved in the supernatant  at day 7. 
Because production of J  chain may be required  for secretion of polymeric immu- 
noglobulins,  plasma cells from  7-d cultures  were stained  by double contrast  immu- 
nofluorescent techniques with rhodamine-tagged anti-J chain and fluorescein-tagged 
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anti IgA1,  anti  IgA2, or anti-total IgA. J  chain staining was detected in 93% of the 
plasma cells stained for IgA1, 91% of the cells positive for IgA2, and 91% of the cells 
stained with heterologous anti IgA. 
Discussion 
The results demonstrate a surprising discordance between two measures of in vitro 
B cell maturation. Although 50% of the IgA plasma cells in a  7-d PWM-stimulated 
culture express IgA~,  as  demonstrated  by cytoplasmic immunofluorescent staining, 
<10%  of the  IgA  released into  the culture supernatants  is  IgA2.  This  discrepancy 
cannot be explained by selective loss or destruction of IgAz in the culture supernatants; 
if  known amounts of  purified IgA2 myeloma proteins of  either AM2 + or Am2- allotype 
(6)  were added at  the  beginning of the culture period, then 67-83%  of the added 
protein could be retrieved from the supernatant at the end of culture. 
The observation that there were approximately equal amounts of IgA1 and IgA2 in 
lysates  of the  cell  pellets  demonstrates  that  the  radioimmunoassay  used  in  these 
experiments is able to detect in vitro synthesized IgA2. It also verifies the results of the 
immunofluorescent staining, which indicated that there were equal numbers of IgA1 
and IgA2 plasma cells. The IgA2 plasma ceils were not morphologically different from 
the IgA~ plasma  cells. Cell  size, nucleus/cytoplasm ratio,  and  intensity of staining 
were equal in the two subpopulations. 
In past experiments it was noted that early in the PWM-stimulated culture there 
was a predominance of IgAa plasma cells, but that by 7 d of culture there were equal 
numbers of plasma cells expressing IgA1 and IgAz (5). This suggested a relative delay 
in  the maturation  of IgA2  plasma  cells.  However, even when  culture periods were 
extended to  12 d, <10%  of the IgA in the culture supernatants  was  IgA2,  and  this 
proportion did not increase over time. Furthermore, there was always more IgA2  in 
the cell pellet than in the culture supernatant, whereas there was always more IgA~ in 
the supernatant than in the cell pellet. In several experiments <1% of the IgA in the 
culture supernatant was IgA2. It is possible that in the cultures in which 5-10% of the 
IgA  in  the  supernatant  was  IgA2  that  the  IgA2  was  not  released  in  the course of 
normal metabolic processes, but instead was the result of spontaneous cell death and 
lysis. 
Other investigators have postulated  that J  chain  may have a  regulatory role in 
antibody secretion  (7).  Therefore, IgA plasma  cells were counter-stained with anti- 
human-J chain to determine if the failure to secrete lgA2 might be associated with a 
failure to produce J  chain. As demonstrated by Mestecky et al.  (8), almost all IgA 
plasma cells could be stained for J  chain, including 93% of the IgA1 plasma cells and 
91% of the IgAz plasma cells. 
It is not clear why IgA2 is not secreted into culture media. It is possible that some 
terminal biochemical modification such as glycosylation (9) is incomplete. Ciccimarra 
et al. (10) demonstrated that some patients with common variable agammaglobuline- 
mia  have B  cells  that  differentiate into  IgG-containing plasma  cells  but  not  IgG- 
secreting cells.  The failure to secrete immunoglobulin was associated with a defect in 
the incorporation of [SH]mannose and [3H]glucosamine into newly synthesized IgG. 
But, if terminal modifications are unfinished, the critical question becomes, why is 
the  differentiation  of IgA1  plasma  cells  complete  and  that  of IgA2  plasma  cells 
incomplete? It  is possible  that  the two subpopulations  of plasma  cells are  derived 1620  IN VITRO REGULATION OF  IgA SUBCLASS SYNTHESIS 
from B  cells  that  are  at  different  stages of maturation.  Mature  IgA B  cells  in  the 
peripheral circulation express predominantly IgA1, whereas the less mature cells that 
express surface IgM as well as IgA are equally divided between  those bearing IgA1 
and IgAz (4). It is possible that both the mature and immature B cells can differentiate 
into plasma cells in response to PWM,  but only the more mature cells differentiate 
into immunoglobulin-secreting cells. This is unlikely to be the complete explanation 
because between 6  and 37% of the mature IgA B cells in the peripheral circulation 
express  IgA2, whereas  only  0.2-9%  of the  IgA in  culture  supernatant  is  IgA2.  In 
addition, other investigators (I i) have demonstrated that relatively immature B cells 
that express surface IgM can give rise to IgG-secreting cells in a PWM-driven system. 
Other investigators (12,  13) have suggested that the different assays used to measure 
B  cell  differentiation  might  not  be measuring  equivalent  phenomena.  The  reverse 
hemolytic plaque assay (12,  13), quantitation ofimmunoglobulin released into culture 
supernatant  (13-15), and enumeration of cells positive for cytoplasmic immunoglob- 
ulin  (12,  15,  16)  are  all  frequently  cited  measurements of B  cell  function,  but  the 
relationship  between  them  is  not  well  established.  The  number of plaque-forming 
cells derived from 106 PWM-stimulated cells is usually reported as between 6 and 60 
×  10  a (12,  13),  whereas  the number of plasma cells positive for cytoplasmic immu- 
noglobulin derived from the same number of cells is usually between 5 and 50 ×  104 
(12,  15,  16). This suggests that not all cells that have the morphologic and histochem- 
ical  appearance  of  plasma  cells  are  actually  secreting  immunoglobulin.  Further, 
Munoz  et  al.  (13)  demonstrated  a  lack  of  correlation  between  the  quantity  of 
immunoglobulin secreted into culture supernatants and the number of plaque-forming 
ceils from the same experiment. This suggests that not all immunoglobulin-secreting 
cells secrete equal amounts of immunoglobulin. 
The results presented in this paper indicate that the precursors of IgA2-producing 
ceils can be successfully stimulated by PWM  to differentiate into IgA2 plasma cells 
but  only inefficiently into IgA2-secreting cells. This suggests that  additional  signals 
may  be  required  for  terminal  differentiation  of  these  cells;  signals  that  may  be 
provided at mucosal surfaces. The results also indicate that a cell with the phenotypic 
appearance of a plasma cell may not be at the final stage of differentiation. 
Summary 
To investigate the in  vitro regulation  of IgA subclass synthesis,  peripheral  blood 
lymphocytes from healthy adults were cultured with the polyclonal B cell activator, 
pokeweed mitogen. Although  50%  of the IgA plasma cells from a  7-d culture were 
positive for cytoplasmic IgA1 and 50% were positive for IgA2, <Z 10% of the IgA released 
into the culture supernatant  was IgA2. This discrepancy could not  be explained by 
failure of the assay to detect in vitro synthesized IgA2, selective loss or destruction of 
IgA2  in  culture  media,  delayed  release  of IgAz, or  failure  of IgA2  plasma  cells  to 
produce J  chain. The results suggest that additional  signals may be required  for the 
differentiation of plasma cells into immunoglobulin-secreting cells. 
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